DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 8Dr. Reddy's Laboratories
02 2Olpha
03 6Granules India Limited
04 42care4
05 1Accord healthcare
06 2Adamed Pharma
07 1Alhavi Pharma
08 2Alkem Laboratories
09 2Alter Laboratories Sa
10 2Annora Pharma
11 1Aurobindo Pharma Limited
12 1Aurovitas Spain, Sau
13 1Bausch Health
14 69Boehringer Ingelheim GmbH
15 3CLONMEL HLTHCARE
16 2Cinfa Laboratories Sa
17 1Combix Laboratories Slu
18 1Demo S.A.
19 3Grindeks AS
20 3Grupo Azevedos
21 4Intas Pharmaceuticals
22 1Intas Third Party Sales 2005 Sl
23 1InvaGen Pharmaceuticals Inc
24 1Kern Pharma S.L.
25 2Kinapse
26 2Krka
27 3Laboratorios Lafage
28 3MEDOCHEMIE LTD
29 6MSN Laboratories
30 1Mahban Group
31 4PharOS Ltd
32 5PharmaPath S.A.
33 4Pharmaline
34 1Pharmapath Sa
35 2Pharos Pharmaceutical Oriented Services Ltd.
36 3Pluviaendo
37 3Prinston
38 8STADA Arzneimittel
39 11Sandoz B2B
40 3Sun Pharmaceutical Industries Limited
41 4Sunshine Lake Pharma
42 2Tarbis Farma Sl
43 2Tecnimede
44 3Varian Pharmed
45 8Viatris
46 6Zentiva
47 4Zydus Pharmaceuticals
01 3Each Coated Tablet
02 95Film Coated Tablet
03 4Film Coated Tablet
04 14Film-Coated Tablet
05 6Immediate Release Tablet
06 1Linagliptin 5Mg 28 Combined Oral Use
07 1Metformin+Linagliptin+2,51,000 Mg 56 Combined Oral Use
08 1Metformin+Linagliptin+2,5850 Mg 56 Combined Oral Use
09 4Oral Solid Dosage Form
10 4TABLET
11 6TABLET, EXTENDED RELEASE;ORAL
12 4TABLET; ORAL
13 38TABLET;ORAL
14 19Tablet
15 2Tablets
16 1Tablets
17 2tablet
18 7Blank
01 5Allowed
02 10Approved
03 18Authorised
04 39Authorized
05 1Dossier Readiness: Q1 2025
06 2Generic
07 4Lead Market Dossiers- Filed
08 6Marketed
09 8Not Marketed
10 18Prescription
11 31RX
12 1Withdrawn
13 69Blank
01 2Autnami
02 1Diagliptin Deo
03 1Donumid
04 1Drojarto
05 3EMPAGLIFLOZIN AND LINAGLIPTIN
06 6EMPAGLIFLOZIN; LINAGLIPTIN
07 2Empagliflozin ; Linagliptin
08 1Empiria Complex
09 1Empiria Complex
10 2GLYXAMBI
11 2Girl Duet
12 2Glymetia
13 10Glyxambi
14 1Glyxambi
15 2Ilinpru
16 6JENTADUETO
17 2JENTADUETO XR
18 26Jentadueto
19 3Jentadueto mg
20 7LINAGLIPTIN
21 1LINAGLIPTIN 5
22 17LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
23 3LINAGLIPTIN; METFORMIN HYDROCHLORIDE
24 1Liglinra
25 1Linagliptin
26 3Linagliptin ; Metformin Hydrochloride
27 1Linagliptin Accord
28 1Linagliptin Aurovitas
29 1Linagliptin Combix
30 1Linagliptin Intas
31 1Linagliptin Kern Pharma
32 1Linagliptin Krka
33 1Linagliptin Medochemie5
34 1Linagliptin Medochemistry
35 1Linagliptin Olpha
36 1Linagliptin Pharos
37 3Linagliptin Sandoz
38 1Linagliptin Stada
39 2Linagliptin Viatris
40 1Linagliptin Zentiva
41 2Linagliptin/Metformin Cinfa
42 3Linagliptin/Metformin Clonmel
43 3Linagliptin/Metformin Hcl Pharos
44 2Linagliptin/Metformin Pharos
45 3Linagliptin/Metformin Sandoz
46 3Linagliptin/Metformin Stada
47 2Linagliptin/Metformin Tarbis
48 1Linagliptina Alter
49 1Linagliptina Medochemie
50 1Linagliptina Pharmapath
51 1Linagliptina Stada
52 2Linagliptina/Metformina Sandoz
53 2Linagliptine/Metformin Stada
54 1Linathan
55 1Lynxaram
56 2Meglithan
57 1Melijent
58 1Sansik
59 1TRADJENTA
60 1TRAJENTA
61 4TRIJARDY XR
62 1Tingapla
63 9Trajenta
64 6Trajentamet
65 1Zyfoqam
66 33Blank
01 12Australia
02 4Canada
03 4Czech Republic
04 14Estonia
05 3Guatemala
06 14India
07 5Iran
08 3Italy
09 4Latvia
10 4Lebanon
11 19Malta
12 14Norway
13 2Poland
14 5Portugal
15 39Spain
16 10Sweden
17 5Switzerland
18 3Turkey
19 48USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;500MG
Packaging :
Approval Date : 2025-11-03
Application Number : 208427
Regulatory Info : RX
Registration Country : USA
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Regulatory Info : Dossier Readiness: Q1 2025
Registration Country : Latvia
Brand Name :
Dosage Form : Tablet
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Readiness: Q1 2025
Registration Country : Latvia
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Empagliflozin ; Linagliptin
Dosage Form : Immediate Release Tablet
Dosage Strength : 10MG; 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;850MG
Packaging :
Approval Date : 2025-11-03
Application Number : 208427
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;1GM
Packaging :
Approval Date : 2025-11-03
Application Number : 208427
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : LINAGLIPTIN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2025-11-03
Application Number : 208428
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 2MG; 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 2MG; 850MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 2MG; 1G
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Linagliptin Olpha
Dosage Form : Film Coated Tablet
Dosage Strength : 5MG
Packaging :
Approval Date : 24-11-2025
Application Number : 90773
Regulatory Info : Authorized
Registration Country : Spain
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Empagliflozin ; Linagliptin
Dosage Form : Immediate Release Tablet
Dosage Strength : 25MG; 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Linagliptin
Dosage Form : Immediate Release Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Linagliptin ; Metformin Hydrochloride
Dosage Form : Immediate Release Tablet
Dosage Strength : 2.5MG; 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Linagliptin ; Metformin Hydrochloride
Dosage Form : Immediate Release Tablet
Dosage Strength : 2.5MG; 850MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Linagliptin ; Metformin Hydrochloride
Dosage Form : Immediate Release Tablet
Dosage Strength : 2.5MG; 1000MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : TRADJENTA
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2011-05-02
Application Number : 201280
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : JENTADUETO
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;500MG
Packaging :
Approval Date : 2012-01-30
Application Number : 201281
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : JENTADUETO
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;850MG
Packaging :
Approval Date : 2012-01-30
Application Number : 201281
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : JENTADUETO
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;1GM
Packaging :
Approval Date : 2012-01-30
Application Number : 201281
Regulatory Info : RX
Registration Country : USA
